Filter Results :

Your search for Diseases returned 96 reports

Sort by


Global Sexually Transmitted Diseases Partnering 2012-2018

01 Mar 2018  |  Published by:  CurrentPartnering
The Global Sexually Transmitted Diseases Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.• Trends in partnering deals• Top deals by value• Deals listed by company A-Z, indu...

$ 1,495.00

Read More

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

07 Feb 2018  |  Published by:  GBI Research
SummaryNeurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies.Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), lead...

$ 4,995.00

Read More

US Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report...

$ 3,850.00

Read More

UK Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report...

$ 2,200.00

Read More

Spain Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The r...

$ 2,200.00

Read More

Japan Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The ...

$ 2,600.00

Read More

Italy Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The r...

$ 2,200.00

Read More

Germany Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The re...

$ 2,200.00

Read More

France Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 322-page report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The re...

$ 2,200.00

Read More

Global Enteric Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About ...

$ 11,500.00

Read More

US Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 283-page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume...

$ 3,600.00

Read More

UK Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume...

$ 1,950.00

Read More

Spain Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 281-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test v...

$ 1,950.00

Read More

Japan Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
About This Report This new 282-page report from VPGMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The re...

$ 2,400.00

Read More

Italy Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies-Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Technology and Instrumentation Review, Emerging Opportunities

17 Jan 2018  |  Published by:  VPG Market Research
This new 281-page report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test v...

$ 1,950.00

Read More
Total 96 records.